Pipeline
R&D
Careers
Contact
Investor Relations Home
News Releases
Events, Webcasts & Presentations
Corporate Governance
Stock Information
Annual Reports & SEC Filings
Analysts
Information Request
| Print Page |
| E-mail Page |
| RSS Feeds |
| E-mail Alerts |
Investor Relations Home
 | Webcast Q4 Earnings Call- Full Year and Fourth Quarter 2009 Financial Results Conference Call (Replay) 02/23/10 at 4:30 p.m. ET |
| ||||||||||||||||
| Webcast FACET BIOTECH CORP at Biotechnology Industry Organization CEO & Investor Conference (Replay) 02/09/10 at 8:30 a.m. ET |
| ||||||||||||
 |
 | Fourth Quarter and Full Year 2009 Financial Results Presentation |
|
| Corporate Profile |
With several products currently in the clinic and a long-term vision for our future, Facet Biotech is a small but sophisticated biotechnology company focused on research, discovery, innovation and development. Using a disciplined, sophisticated, biology-driven approach, our company is dedicated to advancing our current pipeline of four clinical-stage products and leveraging our research and development capabilities to identify and develop new drugs. We are passionate and committed about the...
More >> |
| Recent News | More >> |
| 03/09/10 - 5:05 p.m. Abbott Enhances Pharmaceutical Pipeline with Acquisition of Facet Biotech |
| 02/23/10 - 4:09 p.m. Facet Biotech Reports Fourth Quarter and Full Year 2009 Financial Results |
| 02/16/10 - 12:57 p.m. Daclizumab shows potential for new immunoregulatory approach to treating MS |
|
| Upcoming Events | More >> |
| There are currently no events scheduled. |
|
Receive E-mail Alerts |
| Sign up to receive e-mail alerts whenever Facet Biotech Corporation posts new information to the site. Just enter your e-mail address and click Submit. |
|
| Contact Information |
| Investor Relations Phone: 650-454-1508 Fax: 650-454-1488 E-mail: Investor.Relations@facetbiotech.com |
|
 Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. |